Navigation Links
Professor Bruce Beutler Joins aTyr Pharma's Scientific Advisory Board
Date:8/3/2009

SAN DIEGO, Aug. 3 /PRNewswire/ -- aTyr Pharma announced today that Bruce Beutler, M.D., Professor and Chairman of the Department of Genetics at The Scripps Research Institute (TSRI), has joined their scientific advisory board. An elected member of both the National Academy of Sciences and the Institute of Medicine, Dr. Beutler was awarded the 2009 Albany Medical Center Prize, one of the largest and most prestigious awards for medicine in the US, in recognition of his contributions to our understanding of the immune system and the translation of that research into therapies that have reduced suffering for millions of patients with inflammatory disease. Dr. Beutler is the inventor of Enbrel(R), the prototype for the most successful class of biotherapeutics ever developed: recombinant inhibitors of TNF that are used to treat inflammatory diseases such as rheumatoid arthritis.

aTyr Pharma's discovery candidates for anti-inflammatory and other indications are based on a novel class of naturally occurring proteins, resectins of tRNA synthetases. Jeff Watkins, CEO of aTyr Pharma, explains the significance of Dr. Beutler's involvement with aTyr Pharma: "The tRNA synthetases play a fundamental role in protein synthesis, but tRNA synthetases in humans have resected forms ("resectins") which provide additional essential activities, such as cell signaling. aTyr Pharma has discovered proprietary resectins with anti-inflammatory activities. Dr. Beutler is the pre-eminent figure in inflammation research, and we hope to capitalize on his experience to develop these proteins as biotherapeutics for treatment of inflammatory diseases as quickly as possible."

Professor Paul Schimmel of TSRI and co-founder of aTyr Pharma adds, "I greatly admire the scientific advances Dr. Beutler has made with inflammation in humans and his ability to turn his discoveries into therapeutics that have had a significant impact on the improvement of human health. We are honored to have him on our scientific advisory board as we think he will make valuable contributions to the understanding and development of aTyr Pharma's novel class of therapeutic proteins."

Dr. Beutler received his undergraduate degree from University of California San Diego, his MD from the University of Chicago, and did his residency at the University of Texas Southwestern Medical Center (UTSMC), before going on to build his research career at the Rockefeller University, at UTSMC as a Howard Hughes investigator, and at TSRI. He has co-authored more than 300 papers that have been cited over 38,000 times by other scientists. Best known for his revolutionary studies on the genetics and molecular basis of inflammation and innate immunity, Dr. Beutler discovered the key role TNF plays in the inflammatory response.

About aTyr Pharma

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery of an entirely new class of biologics. aTyr Pharma's discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These proteins are being developed as novel therapeutics to treat cancer, neurodegenerative diseases, inflammation, cardiovascular diseases and metabolic disorders.

www.atyrpharma.com


'/>"/>
SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Brown professor continues debate over recovered memory
2. Colorado professor recognized for outstanding published work in public health systems research
3. University of Hawaii at Manoa professors co-author adolescent obesity study
4. Dr. Anthony Sandler Named to the Diane and Norman Bernstein Professorship in Pediatric Surgery at Children's National Medical Center
5. Penn State professor investigates estrogen, heart disease connection in women
6. K-State professor awarded $1.48 million to study LASIK complictions
7. Nobel Prize Winner Professor Muhammad Yunus Leading Delegation From Bangladesh to World Health Care Congress to Advance Affordable Health Care Innovations
8. UCSF professor to receive IADR Pulp Biology and Regeneration Award
9. IADR Oral Medicine and Pathology Research Award presented to UCLA professor
10. Pulmo BioTech Inc. Announces Appointment of Professor John Wallwork as Chairman
11. U of Minnesota professor authors report the state of health care journalism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, ... named to the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private ... of 139 percent, marking the twelfth year that the company has been included ...
(Date:8/23/2017)... ... August 23, 2017 , ... The non-profit ... holding an inaugural State of the Science Symposium in partnership with the Global ... 2017. , This symposium provides a forum for global leaders in human nutrition ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... pleased to announce the addition of Zack Tisch as the firm’s new Consulting ... KLAS-ranked healthcare IT consulting firm’s national accounts, from assisting clients with initial vendor ...
(Date:8/22/2017)... ... August 22, 2017 , ... “To Walk Away”: ... a B17 bomber named Edward Koontz. “To Walk Away” is the creation of published ... has published over two hundred manuscripts in chemistry and religion, as well as four ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... the Founder and Managing Member for t4 Leadership Development & Consulting. He has ... his definition of “success”: physician leadership development, servant leadership, data driven process improvement, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- AOTI Inc. announced today that its fully owned USA ... New York City Office in Yonkers, New York ... Oxygen (TWO 2 ) homecare therapy. This new East Coast location ... (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. ...
(Date:8/10/2017)... -- Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, ... . The reputable clinic will continue to be co-owned and ... staff of four clinicians. Lipkin received his doctorate in physical ... years of experience with a strong background in manual therapy. ... 10th PRN clinic in and around the Denver ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
Breaking Medicine Technology: